Skip to main content
OpenTrials
Completed

NCT Number: NCT02922062

The Effects of Consuming Palm Oil With Different Macronutrient Intakes on Blood Lipids

The purpose of this study is to determine the effects of palm oil when consumed as either part of a low carbohydrate diet or a high carbohydrate diet on blood lipids, cardiovascular health and inflammation. The study will help us better understand how the quality of saturated fat and the quantity of carbohydrate interact to impact blood lipids and cardiovascular health.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cardiovascular Diseases Inflammation Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

21 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Physical Activity and Education Services (PAES) Building

Columbus, Ohio, 43210, United States

About this study

The purpose of this study is to determine the effects of palm oil on blood lipids, cardiovascular health and inflammation. Potential subjects will be screened until 24 qualifying healthy participants are enrolled. After enrollment participants will undergo a baseline battery of tests including blood draws, body composition, measures of height and weight, blood lipid profile (cholesterol, lipoprotein particle size, quantity and fatty acid composition), insulin sensitivity using a static index, inflammation, antioxidant status and measurement of energy expenditure and substrate oxidation by indirect calorimetry. Participants will be randomly divided into one of two arms/tracks, either a low carbohydrate diet arm or a high carbohydrate diet arm. Each diet arm consists of 3 phases a low saturated fat control diet where the primary cooking oil is canola oil and two saturated fat diet phases where the primary cooking oil is either palm oil or butter.

Participants will begin with the low saturated fat diet phase first which consists of 50% of fat calories derived from canola oil for 3 weeks. At the end of this control diet phase the battery of tests completed at baseline will be repeated. After a 2-week washout period participants will then proceed in random order into either the palm oil or butter diet phases of their diet arm/track. The palm oil and butter diet phases are also 3 weeks in duration and separated by a 2 week washout period. The palm oil and butter diet phases will derive 50% of the fat calories from either palm oil or butter. Both oils are high in saturated fat but differ in the quality of saturated fat. At the end of each diet phase the testing battery completed at baseline will be repeated. The subjects will never be exposed to more than minimal risk and in return will receive 9 weeks of food, individualized reports of their study results and a monetary stipend. The study will help us better understand how the quality of saturated fat and the quantity of carbohydrate interact to impact blood lipids and cardiovascular health. This knowledge can be used to aid dietary recommendations for cardiovascular health and control of blood lipids.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • normocholesterolemic

Exclusion criteria

  • hypercholesterolemia
  • diabetes
  • liver disease
  • kidney disease
  • other metabolic or endocrine dysfunction
  • diagnosis of cancer within the previous 5 years
  • hypertension
  • current use of cholesterol reducing medications
  • current use of diabetic medications

Treatment and study plan

Canola Oil

Other

Subjects will be provided with all their meals prepared in our metabolic kitchen in order to control their diets. The major cooking oil used in food preparation will be canola oil. The meals will be tailored to the caloric needs of each individual in order to maintain their body weight.

Other names: low saturated fat control, Controlled Dietary Intervention using Canola Oil

Palm oil

Other

Subjects will be provided with all their meals prepared in our metabolic kitchen in order to control their diets. The major cooking oil used in food preparation will be palm oil. The meals will be tailored to the caloric needs of each individual in order to maintain their body weight.

Other names: saturated fat, Controlled Dietary Intervention using Palm Oil

Butter

Other

Subjects will be provided with all their meals prepared in our metabolic kitchen in order to control their diets. The major cooking oils used in food preparation will be butter. The meals will be tailored to the caloric needs of each individual in order to maintain their body weight.

Other names: saturated fat, Controlled Dietary Intervention using Butter

Primary outcomes

  1. Change in High-Density Lipoprotein (HDL) Particle Size between Canola Oil and Palm Oil Diet Phases (Part of the Lipoprotein Distribution)

    Time frame: Assessed during the 3rd week of the canola oil and palm oil diet

    The change in HDL particle size and the number of each size particle between Canola Oil and Palm Oil diets will be assessed by Nuclear Magnetic Resonance (NMR) spectroscopy

  2. Change in HDL Particle Size between Canola Oil and Butter Diet Phases (Part of the Lipoprotein Distribution)

    Time frame: Assessed during the 3rd week of the canola oil and butter diets

    The change in HDL particle size and the number of each size particle between Canola Oil and Butter diets will be assessed by Nuclear Magnetic Resonance (NMR) spectroscopy

  3. Change in Low-Density Lipoprotein (LDL) Particle Size between Canola Oil and Palm Oil Diet Phases (Part of the Lipoprotein Distribution)

    Time frame: Assessed during the 3rd week of the canola oil and palm oil diets

    The change in LDL particle size and the number of each size particle between Canola Oil and Palm Oil diets will be assessed by NMR spectroscopy

  4. Change in LDL Particle Size between Canola Oil and Butter Diet Phases (Part of the Lipoprotein Distribution)

    Time frame: Assessed during the 3rd week of the canola oil and butter diets

    The change in LDL particle size and the number of each size particle between Canola Oil and Palm Oil diets will be assessed by NMR spectroscopy

  5. Change in Very Low-Density Lipoprotein (VLDL) Particle Size between Canola Oil and Palm Oil Diet Phases (Part of the Lipoprotein Distribution)

    Time frame: Assessed during the 3rd week of the canola oil and palm oil diets

    The change in VLDL particle size and the number of each size particle between Canola Oil and Palm Oil diets will be assessed by NMR spectroscopy

  6. Change in VLDL Particle Size between Canola Oil and Butter Diet Phases (Part of the Lipoprotein Distribution)

    Time frame: Assessed during the 3rd week of the canola oil and butter diets

    The change in VLDL particle size and the number of each size particle between Canola and Butter diets will be assessed by NMR spectroscopy

Secondary outcomes

  1. Change in Insulin Sensitivity between the Canola Oil and Palm Oil Diet Phases

    Time frame: Assessed during the 3rd week of the canola oil and palm oil diets

    The change in glucose and insulin between Canola Oil and Palm Oil diets will be measured from plasma to determine the Homeostasis Model Assessment (HOMA) index score

  2. Change in Insulin Sensitivity between the Canola Oil and Butter Diet Phases

    Time frame: Assessed during the 3rd week of the canola oil and butter diets

    The change in glucose and insulin between Canola Oil and Palm Oil diets will be measured from plasma to determine the Homeostasis Model Assessment (HOMA) index score

  3. Change in Body Weight between the Canola Oil and Palm Oil Diet Phases

    Time frame: Assessed during the 3rd week of the canola oil and palm oil diets

    The change in body mass between Canola Oil and Palm Oil diets will be measured on a scale

  4. Change in Body Weight between the Canola Oil and Butter Diet Phases

    Time frame: Assessed during the 3rd week of the canola oil and butter diets

    The change in body mass between Canola Oil and Butter diets will be measured on a scale

  5. Change in Body Composition (Percent of Lean Mass, Fat Mass and Bone Mass according to the 3-compartment Model) between the Canola Oil and Palm Oil Diet Phases

    Time frame: Assessed during the 3rd week of the canola oil and palm oil diets

    The change in body composition between Canola Oil and Palm Oil diets will be measured by dual-energy X-ray absorptiometry

  6. Change in Body Composition (Percent of Lean Mass, Fat Mass and Bone Mass according to the 3-compartment Model) between the Canola Oil and Butter Diet Phases

    Time frame: Assessed during the 3rd week of the canola oil and butter diets

    The change in body composition between Canola Oil and Butter diets will be measured by dual-energy X-ray absorptiometry

  7. Change in the Cholesterol Profile between the Canola Oil and Palm Oil Diet Phases (Part of the Cholesterol Profile)

    Time frame: Assessed during the 3rd week of the canola oil and palm oil diets

    The change in total cholesterol and HDL cholesterol between Canola Oil and Palm Oil diets will be measured by immunoturbidimetry and LDL cholesterol will be calculated using these two values.

  8. Change in the Cholesterol Profile between the Canola Oil and Butter Diet Phases (Part of the Cholesterol Profile)

    Time frame: Assessed during the 3rd week of the canola oil and butter diets

    The change in total cholesterol and HDL cholesterol between Canola Oil and Butter diets will be measured by immunoturbidimetry and LDL cholesterol will be calculated using these two values.

  9. Change in Total Triglycerides between the Canola Oil and Palm Oil Diet Phases (Part of the Cholesterol Profile)

    Time frame: Assessed during the 3rd week of the canola oil and palm oil diets

    The change in triglycerides between Canola Oil and Palm Oil diets will be measured by immunoturbidimetry

  10. Change in Total Triglycerides between the Canola Oil and Butter Diet Phases (Part of the Cholesterol Profile)

    Time frame: Assessed during the 3rd week of the canola oil and butter diets

    The change in triglycerides between Canola Oil and Butter diets will be measured by immunoturbidimetry

  11. Change in the Apolopoprotein-A1 Concentration in plasma between the Canola Oil and Palm Oil Diet Phases (Part of the Cholesterol Profile)

    Time frame: Assessed during the 3rd week of the canola oil and palm oil diets

    The change in Apolopoprotein-A1 between Canola Oil and Palm Oil diets will be assessed by ELISA

  12. Change in the Apolopoprotein-A1 Concentration in plasma between the Canola Oil and Butter Diet Phases (Part of the Cholesterol Profile)

    Time frame: Assessed during the 3rd week of the canola oil and butter diets

    The change in Apolopoprotein-A1 between Canola Oil and Butter diets will be assessed by ELISA

  13. Change in the Apolopoprotein-B Concentration in plasma between the Canola Oil and Palm Oil Diet Phases (Part of the Cholesterol Profile)

    Time frame: Assessed during the 3rd week of the canola oil and Palm Oil diets

    The change in Apolopoprotein-B between Canola Oil and Palm Oil diets will be assessed by ELISA

  14. Change in the Apolopoprotein-B Concentration in plasma between the Canola Oil and Butter Diet Phases (Part of the Cholesterol Profile)

    Time frame: Assessed during the 3rd week of the canola oil and butter diets

    The change in Apolopoprotein-B between Canola Oil and Butter Diets will be assessed by ELISA

  15. Change in the Fatty Acid Composition of the Plasma between the Canola Oil and Palm Oil Diet Phases

    Time frame: Assessed during the 3rd week of the canola oil and palm oil diets

    Teh change in the fatty acid composition of the plasma between Canola Oil and Palm Oil diets will be assessed by gas chromatography using flame ionization detection

  16. Change in the Fatty Acid Composition of the Plasma between the Canola Oil and Butter Diet Phases

    Time frame: Assessed during the 3rd week of the canola oil and butter diets

    The change in the fatty acid composition of the plasma between Canola Oil and Butter will be assessed by gas chromatography using flame ionization detection

Other outcomes

  1. Change in C-Reactive Protein between the Canola Oil and Palm Oil Diet Phases (Part of an Inflammatory Panel)

    Time frame: Assessed during the 3rd week of the canola oil and palm oil diets

    The change in C-Reactive Protein between Canola Oil and Palm Oil diets will be assessed using a multiplex ELISA platform

  2. Change in C-Reactive Protein between the Canola Oil and Butter Diet Phases (Part of an Inflammatory Panel)

    Time frame: Assessed during the 3rd week of the canola oil and butter diets

    The change in C-Reactive Protein between Canola Oil and Palm Oil diets will be assessed using a multiplex ELISA platform

  3. Change in Interleukin (IL)-1beta Protein between the Canola Oil and Palm Oil Diet Phases (Part of an Inflammatory Panel)

    Time frame: Assessed during the 3rd week of the canola oil and palm oil diets

    The change in IL-1beta between Canola Oil and Palm Oil diets will be assessed using a multiplex ELISA platform

  4. Change in IL-1beta Protein between the Canola Oil and Butter Diet Phases (Part of an Inflammatory Panel)

    Time frame: Assessed during the 3rd week of the canola oil and butter diets

    The change in IL-1beta between Canola Oil and Butter diets will be assessed using a multiplex ELISA platform

  5. Change in Tumor Necrosis Factor (TNF)-alpha between the Canola Oil and Palm Oil Diet Phases (Part of an Inflammatory Panel)

    Time frame: Assessed during the 3rd week of the canola oil and palm oil diets

    The change in TNF-alpha between Canola Oil and Palm Oil diets will be assessed using a multiplex ELISA platform

  6. Change in TNF-alpha between the Canola Oil and Butter Diet Phases (Part of an Inflammatory Panel)

    Time frame: Assessed during the 3rd week of the canola oil and butter diets

    The change in TNF-alpha between Canola Oil and Palm Oil will be assessed using a multiplex ELISA platform

  7. Change in Neopterin between the Canola Oil and Palm Oil Diet Phases (Part of an Inflammatory Panel)

    Time frame: Assessed during the 3rd week of the canola oil and palm oil diets

    The change in TNF-alpha between Canola Oil and Palm Oil diets will be assessed using a singleplex ELISA platform

  8. Change in Neopterin between the Canola Oil and Butter Diet Phases (Part of an Inflammatory Panel)

    Time frame: Assessed during the 3rd week of the canola oil and butter diets

    The change in Neopterin between Canola Oil and Butter diets will be assessed using a singleplex ELISA platform

  9. Change in Elastase between the Canola Oil and Palm Oil Diet Phases (Part of an Inflammatory Panel)

    Time frame: Assessed during the 3rd week of the canola oil and palm oil diets

    The change in Elastase between Canola Oil and Palm Oil diets will be assessed using a singleplex ELISA platform

  10. Change in Elastase between the Canola Oil and Butter Diet Phases (Part of an Inflammatory Panel)

    Time frame: Assessed during the 3rd week of the canola oil and butter diets

    The change in Elastase between Canola Oil and Butter diets will be assessed using a singleplex ELISA platform

  11. Change in Conjugated Dienes between the Canola Oil and Palm Oil Diet Phases (Part of an Antioxidant Status Assessment)

    Time frame: Assessed during the 3rd week of the canola oil and palm oil diets

    The change in Conjugated dienes, an early stage lipid peroxidation product, between Canola Oil and Palm Oil diets will be assessed by spectrophotometry.

  12. Change in Conjugated Dienes between the Canola Oil and Butter Diet Phases (Part of an Antioxidant Status Assessment)

    Time frame: Assessed during the 3rd week of the canola oil and butter diets

    The change in Conjugated dienes, an early stage lipid peroxidation product, between Canola Oil and Butter diets will be assessed by spectrophotometry.

  13. Change in Malondialdehyde between the Canola Oil and Palm Oil Diet Phases (Part of an Antioxidant Status Assessment)

    Time frame: Assessed during the 3rd week of the canola oil and palm oil diets

    The change in Malondialdehyde, a late stage lipid peroxidation product, between Canola Oil and Palm Oil diets will be assessed by spectroscopy.

  14. Change in Malondialdehyde between the Canola Oil and Butter Diet Phases (Part of an Antioxidant Status Assessment)

    Time frame: Assessed during the 3rd week of the canola oil and butter diets

    The change in Malondialdehyde, a late stage lipid peroxidation product, between Canola Oil and Butter diets will be assessed by high performance liquid chromatography.

  15. Change in the Total Antioxidant Capacity of the blood between the Canola Oil and Palm Oil Diet Phases (Part of an Antioxidant Status Assessment)

    Time frame: Assessed during the 3rd week of the canola oil and palm oil diets

    The change in the total antioxidant capacity of the blood between Canola Oil and Palm Oil diets will be assessed by spectrophotometry using the Ferric Reducing Antioxidant Power (FRAP) assay.

  16. Change in the Total Antioxidant Capacity of the blood between the Canola Oil and Butter Diet Phases (Part of an Antioxidant Status Assessment)

    Time frame: Assessed during the 3rd week of the canola oil and butter diets

    The change in the total antioxidant capacity of the blood between Canola Oil and Butter diets will be assessed by spectrophotometry using the FRAP assay.

Sponsors and collaborators

Lead sponsor

Ohio State University

Other

Collaborators

  • Malaysia Palm Oil Board

Registry information

Official study title

The Effects of Palm Oil Consumed Under Different Macronutrient Distributions on Circulating Lipoprotein and Fatty Acid Profiles

Important dates

Study start
2016
Primary completion
2018
Study completion
2018
First posted
Oct 3, 2016
Registry last updated
Aug 23, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.